Cigna Investments’s Freeport-McMoran FCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $856K | Hold |
13,609
| – | – | 0.11% | 145 |
|
|
2026
Q1 | $800K | Sell |
13,609
-178
| -1% | -$10.8K | 0.12% | 152 |
|
|
2025
Q4 | $700K | Sell |
13,787
-226
| -2% | -$9.79K | 0.1% | 176 |
|
|
2025
Q3 | $550K | Hold |
14,013
| – | – | 0.08% | 220 |
|
|
2025
Q2 | $608K | Sell |
14,013
-241
| -2% | -$9.15K | 0.1% | 195 |
|
|
2025
Q1 | $540K | Sell |
14,254
-471
| -3% | -$18K | 0.1% | 201 |
|
|
2024
Q4 | $561K | Sell |
14,725
-130
| -0.9% | -$5.82K | 0.1% | 201 |
|
|
2024
Q3 | $742K | Sell |
14,855
-110
| -0.7% | -$4.96K | 0.13% | 160 |
|
|
2024
Q2 | $727K | Sell |
14,965
-182
| -1% | -$9.17K | 0.13% | 148 |
|
|
2024
Q1 | $712K | Buy |
15,147
+36
| +0.2% | +$1.45K | 0.13% | 159 |
|
|
2023
Q4 | $643K | Sell |
15,111
-228
| -1% | -$8.42K | 0.13% | 155 |
|
|
2023
Q3 | $572K | Sell |
15,339
-1,968
| -11% | -$79.3K | 0.13% | 158 |
|
|
2023
Q2 | $692K | Hold |
17,307
| – | – | 0.13% | 158 |
|
|
2023
Q1 | $709K | Sell |
17,307
-346
| -2% | -$14.4K | 0.14% | 147 |
|
|
2022
Q4 | $671K | Sell |
17,653
-118
| -0.7% | -$4.12K | 0.14% | 159 |
|
|
2022
Q3 | $486K | Sell |
17,771
-965
| -5% | -$28.2K | 0.11% | 193 |
|
|
2022
Q2 | $548K | Sell |
18,736
-7,034
| -27% | -$282K | 0.11% | 188 |
|
|
2022
Q1 | $1.28M | Sell |
25,770
-7,317
| -22% | -$324K | 0.16% | 127 |
|
|
2021
Q4 | $1.38M | Sell |
33,087
-11,916
| -26% | -$453K | 0.11% | 148 |
|
|
2021
Q3 | $1.46M | Sell |
45,003
-792
| -2% | -$27.9K | 0.11% | 161 |
|
|
2021
Q2 | $1.7M | Sell |
45,795
-6,664
| -13% | -$260K | 0.12% | 151 |
|
|
2021
Q1 | $1.73M | Buy |
52,459
+1,932
| +4% | +$62.7K | 0.12% | 155 |
|
|
2020
Q4 | $1.31M | Buy |
50,527
+4,282
| +9% | +$89K | 0.1% | 174 |
|
|
2020
Q3 | $724K | Sell |
46,245
-7,976
| -15% | -$115K | 0.07% | 261 |
|
|
2020
Q2 | $627K | Buy |
54,221
+13,361
| +33% | +$122K | 0.06% | 325 |
|
|
2020
Q1 | $276K | Buy |
40,860
+2,400
| +6% | +$25.1K | 0.04% | 471 |
|
|
2019
Q4 | $427K | Sell |
38,460
-3,653
| -9% | -$40.1K | 0.05% | 421 |
|
|
2019
Q3 | $414K | Buy |
42,113
+1,950
| +5% | +$20K | 0.04% | 442 |
|
|
2019
Q2 | $444K | Sell |
40,163
-1,150
| -3% | -$13.4K | 0.05% | 420 |
|
|
2019
Q1 | $532K | Sell |
41,313
-18,125
| -30% | -$219K | 0.06% | 371 |
|
|
2018
Q4 | $614K | Sell |
59,438
-204
| -0.3% | -$2.38K | 0.05% | 273 |
|
|
2018
Q3 | $696K | Sell |
59,642
-80,097
| -57% | -$1.21M | 0.06% | 267 |
|
|
2018
Q2 | $2.41M | Buy |
139,739
+62,754
| +82% | +$1.06M | 0.17% | 82 |
|
|
2018
Q1 | $1.35M | Buy |
76,985
+15,421
| +25% | +$289K | 0.09% | 193 |
|
|
2017
Q4 | $1.17M | Buy |
61,564
+10,497
| +21% | +$158K | 0.08% | 217 |
|
|
2017
Q3 | $717K | Sell |
51,067
-343
| -0.7% | -$4.82K | 0.05% | 343 |
|
|
2017
Q2 | $617K | Sell |
51,410
-3,595
| -7% | -$43.6K | 0.04% | 377 |
|
|
2017
Q1 | $735K | Buy |
55,005
+8,931
| +19% | +$128K | 0.05% | 346 |
|
|
2016
Q4 | $608K | Buy |
+46,074
| New | +$589K | 0.07% | 357 |
|
Other funds holding FCX
Cigna Investments's FCX Position: Q2 2026 in Review
Cigna Investments held its Freeport-McMoran (FCX) position steady in Q2 2026 at 13,609 shares worth $856K. The position accounts for 0.11% of the portfolio, ranked #145.
Cigna Investments first reported a position in FCX in Q4 2016 and has held it in 39 quarters since. The position peaked at $2.41M in Q2 2018. 1,888 funds tracked by Wall St. Rank hold FCX as of Q2 2026.
- Cigna Investments held 13,609 shares of Freeport-McMoran worth $856K as of Q2 2026.
- Cigna Investments left its Freeport-McMoran share count unchanged in Q2 2026.
- Freeport-McMoran made up 0.11% of Cigna Investments's portfolio in Q2 2026, its #145 holding.
- Cigna Investments first reported a position in Freeport-McMoran in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Freeport-McMoran position peaked at $2.41M in Q2 2018.
- 1,888 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.